Form 8-K - Current report:
SEC Accession No. 0001193125-25-042468
Filing Date
2025-02-28
Accepted
2025-02-28 16:05:28
Documents
13
Period of Report
2025-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d893104d8k.htm   iXBRL 8-K 22975
  Complete submission text file 0001193125-25-042468.txt   148026

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmea-20250224.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20250224_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20250224_pre.xml EX-101.PRE 11716
15 EXTRACTED XBRL INSTANCE DOCUMENT d893104d8k_htm.xml XML 3760
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 25690005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)